Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome

Blood

Volumn 117, Issue 24, 2011, Pages 6445-6449

  Li, Jian ^a   Zhang, Wei ^a   Jiao, Li ^a   Duan, Ming Hui ^a   Guan, Hong Zhi ^a   Zhu, Wei Guo ^a   Tian, Zhuang ^a   Zhou, Dao Bin ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; MELPHALAN; VASCULOTROPIN;

ADULT; AGED; ANEMIA; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; POEMS SYNDROME; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REMISSION; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

EID: 79959259127     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-12-328112     Document Type: Article

References (16)

1. Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood. 2003;101(7):2496-2506. (Pubitemid 36857604)
2. Watanabe O, Maruyama I, Arimura K, et al. Overproduction of vascular endothelial growth factor/ vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve. 1998;21(11):1390-1397. (Pubitemid 28453125)
3. Dispenzieri A, Gertz MA. Treatment options for POEMS syndrome. Expert Opin Pharmacother. 2005;6(6):945-953. (Pubitemid 40946156)
4. Dispenzieri A, Gertz MA. Treatment of POEMS syndrome. Curr Treat Options Oncol. 2004;5(3): 249-257. (Pubitemid 39359625)
5. Kuwabara S, Hattori T, Shimoe Y, Kamitsukasa I. Long term melphalan-prednisolone chemotherapy for POEMS syndrome. J Neurol Neurosurg Psychiatry. 1997;63(3):385-387. (Pubitemid 27412385)
6. Dispenzieri A, Lacy MQ, Hayman SR, et al. Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome. Eur J Haematol. 2008;80(5): 397-406. (Pubitemid 351503103)
7. Jaccard A, Moreau P, Leblond V, et al. High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. N Engl J Med. 2007; 357(11):1083-1093. (Pubitemid 47443213)
8. Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol. 2005; 79(4):319-328. (Pubitemid 41098849)
9. Graham RC, Hughes R. A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry. 2006; 77(8):973-976. (Pubitemid 44174089)
10. Bastyr EJ 3rd, Price KL, Bril V. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin Ther. 2005;27(8):1278-1294. (Pubitemid 41393921)
11. Hashiguchi T, Arimura K, Matsumuro K, et al. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve. 2000;23(7):1051-1056. (Pubitemid 30437114)
12. Dispenzieri A, Moreno-Aspitia A, Suarez GA, et al. Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood. 2004;104(10):3400-3407. (Pubitemid 39507165)
13. Kuwabara S, Misawa S, Kanai K, et al. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome. Neurology. 2008;71(21):1691-1695.
14. Allam JS, Kennedy CC, Aksamit TR, Dispenzieri A. Pulmonary manifestations in patients with POEMS syndrome: a retrospective review of 137 patients. Chest. 2008;133(4):969-974. (Pubitemid 351536874)
15. Jouve P, Humbert M, Chauveheid MP, Jaïs X, Papo T. POEMS syndrome-related pulmonary hypertension is steroid-responsive. Respir Med. 2007;101(2):353-355. (Pubitemid 46075967)
16. Dispenzieri A. POEMS syndrome. Blood Rev. 2007;21(6):285-299. (Pubitemid 47498680)